HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation between serum calcium levels and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy in primary hyperparathyroidism.

AbstractAIM:
The goal of the study is to correlate serum calcium levels with the results of dual-phase (99m)Tc-sestamibi parathyroid scintigraphy to find the best cut-off level of the serum calcium that correlates with a positive presurgery.
METHODS:
In 111 patients, serum calcium and plasma parathormone (PTH) levels were compared with the results of the (99m)Tc-MIBI scintigraphy and with this data determined the level of calcium above which the (99m)Tc-MIBI scintigraphy was likely to be positive and below which the study was likely to be negative.
RESULTS:
In total, 11 men (18%) and 50 women (82%) had a positive (99m)Tc-MIBI study. Overall 67% of those patients with a positive (99m)Tc-MIBI study had a PTH >200 ng l(-1) compared to only 9% of those with a negative (99m)Tc-MIBI scintigraphy; however, for those with a positive study on an early (99m)Tc-MIBI scintigraphy, this rose to 85%. Overall a serum calcium of >2·70 mmol l(-1) was found in 82% of patients with a positive (99m)Tc-MIBI study but only 14% of those with a negative (99m)Tc-MIBI study, this is rose to 97% of patients with a parathyroid adenoma identified on early images. It is also shown that patients whose serum total calcium <2·51 mmol l(-1) rarely have positive (99m)Tc-MIBI scintigraphy.
CONCLUSION:
(99m)Tc-MIBI parathyroid scintigraphy is most likely to yield identification and localization of a parathyroid adenoma when both PTH and calcium are elevated; however, although there is no lower limit of PTH which can predict a negative study, we cannot recommend (99m)Tc-MIBI parathyroid scintigraphy if the serum calcium is <2·51 mmol l(-1).
AuthorsD S Mshelia, A N Hatutale, N P Mokgoro, M E Nchabaleng, J R Buscombe, M M Sathekge
JournalClinical physiology and functional imaging (Clin Physiol Funct Imaging) Vol. 32 Issue 1 Pg. 19-24 (Jan 2012) ISSN: 1475-097X [Electronic] England
PMID22136277 (Publication Type: Journal Article)
Copyright© 2011 The Authors. Clinical Physiology and Functional Imaging © 2011 Scandinavian Society of Clinical Physiology and Nuclear Medicine.
Chemical References
  • Biomarkers
  • PTH protein, human
  • Parathyroid Hormone
  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi
  • Calcium
Topics
  • Adenoma (blood, complications, diagnosis, diagnostic imaging)
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers (blood)
  • Calcium (blood)
  • Cross-Sectional Studies
  • Female
  • Humans
  • Hypercalcemia (blood, diagnosis, etiology)
  • Hyperparathyroidism, Primary (blood, diagnosis, diagnostic imaging, etiology)
  • Male
  • Middle Aged
  • Multimodal Imaging
  • Parathyroid Glands (diagnostic imaging, metabolism)
  • Parathyroid Hormone (blood)
  • Parathyroid Neoplasms (blood, complications, diagnosis, diagnostic imaging)
  • Positron-Emission Tomography
  • Predictive Value of Tests
  • Prospective Studies
  • Radiopharmaceuticals
  • South Africa
  • Technetium Tc 99m Sestamibi
  • Tomography, X-Ray Computed
  • Up-Regulation
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: